Acumen is forging a new path towards safe and effective treatments for Alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic amyloid-beta oligomers.

Pharmaceutical

Acumen Pharmaceuticals

Acumen Pharmaceuticals' headquarters in Charlottesville, VA, United States

Eric Siemers

Russell Barton

Julie Bockenstette

Matthew Zuga

Derek Meisner

Hao Zhang

Robyn Moxon

Jerry Moore

Kasey Spencer

Kathleen Marcozzi Pierce

Alex Braun

Steve Reynolds

Janice Hitchcock

Katie Rink

Steven DeKosky

Grant Krafft

Colin Masters

Michael Weiner

Cynthia Lemere

Laura Stoppel

Reisa Sperling

William Klein

Jeffrey L. Ives

Sean Stalfort

Kim Drapkin

Lennart Mucke

Derrell D. Porter

Jeffrey Cummings

Stephen Salloway

Nathan B. Fountain

The Research and Development team at Acumen Pharmaceuticals is dedicated to the discovery and optimization of innovative therapies targeting amyloid-beta oligomers for Alzheimer's and other neurodegenerative diseases. Comprising a diverse group of scientific and clinical experts, the team conducts in-depth research, develops drug formulations, and manages clinical trials to bring safe and effective treatments from the lab to patients. Their collaborative efforts focus on advancing our understanding of disease biology while ensuring rigorous development processes that align with regulatory standards.

Research and Development

This department oversees organizational strategy and policy-making at the highest level.

Governance Council

This department provides strategic direction and oversight for organizational initiatives.

Leadership Office

This department oversees the planning, management, and execution of clinical trials to evaluate the safety and efficacy of new medical treatments.

Clinical Development

This department oversees the management and execution of clinical processes and communication initiatives within the organization.

Clinical Operations

The Clinical Operations Team at Acumen Pharmaceuticals is responsible for overseeing and managing clinical trials focused on the development of treatments for Alzheimer's disease. This team ensures that studies are conducted effectively and in compliance with regulatory standards, collaborates on bioanalytical method validation, and maintains high-quality documentation and control processes to support successful trial outcomes. Their efforts are critical in advancing the company’s mission to provide safe and effective therapies for neurodegenerative diseases.

Clinical Operations Team

Acumen Pharmaceuticals

Org chart

Board & advisors

Teams

Research and Development

Governance Council

Leadership Office

Clinical Development

Clinical Operations

Clinical Operations Team

Offices

Acumen Pharmaceuticals

Org chart

Board & advisors

Teams

Research and Development

Governance Council

Leadership Office

Clinical Development

Clinical Operations

Clinical Operations Team

Offices

Related companies